Recall events
/
Event 77247
Event summary
Timeline bucket May 15, 2017
Product types Drug
Classifications Class II
Statuses Terminated
Recalling firm wording Baxter Healthcare Corporation
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
2 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 2
Fluconazole Injection, USP, 200 mg/100 mL (2mg/mL), 100 mL Single-Dose Intravia Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product Code 2J1446, NDC 0338-6046-48
D-0788-2017
Recall number D-0788-2017
Initiated May 15, 2017
Classification Class II
Status Terminated
Quantity 113,590 bags
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility: customer complaints received for the presence of leaks.
Code information Lot #: P344028/P344028A, Exp 12/31/17; P352377, Exp 8/31/18; P348136, Exp 4/30/18
Distribution pattern US and foreign countries: United Arab Emirates, Colombia, and Canada
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[16113]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 2
Milrinone Lactate in 5% Dextrose Injection, 20 mg/100 mL, 100 mL Single-Dose Intravia Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 0338-6010-48
D-0789-2017
Recall number D-0789-2017
Initiated May 15, 2017
Classification Class II
Status Terminated
Quantity 90,450 bags
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of assurance of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of assurance of sterility: customer complaints received for the presence of leaks.
Code information Lot #: P342485, Exp 11/30/17; P344408, Exp 12/31/17
Distribution pattern US and foreign countries: United Arab Emirates, Colombia, and Canada
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[16145]
FDA event record
· Exact recall-number query on openFDA